Mean Percentage Changes in 18F-FDG Uptake in Asymptomatic and Symptomatic HD Subjects
Asymptomatic HD subjects | Symptomatic HD subjects | ||||
---|---|---|---|---|---|
Brain region | Side | 18F-FDG decrease (%) | P | 18F-FDG decrease (%) | P |
Caudate | L | −23.10 | 0.0044* | −34.56 | 0.0000* |
R | −26.53 | 0.0001* | −34.39 | 0.0000* | |
Putamen | L | −14.85 | 0.0003* | −16.67 | 0.0015* |
R | −13.90 | 0.0269 | −19.75 | 0.0058* | |
Frontal | L | −9.52 | 0.0144 | −8.56 | 0.0256 |
R | −11.86 | 0.0037* | −8.57 | 0.0049* | |
Temporal | L | −6.43 | 0.0271 | −3.74 | 0.2199 |
R | −8.05 | 0.0073 | −4.61 | 0.0494 | |
Parietal | L | −2.94 | NS | −0.97 | NS |
R | −4.70 | NS | −2.26 | NS |
↵* Significant after corrections for multiple comparisons.
NS = not significant.
Significant differences from healthy subjects were found in striatum (caudate and putamen) and in frontotemporal cortex of asymptomatic and symptomatic subjects.